GlassScriptPhysician profile
Helen Kindelan
NPI 1902358211
$1,963.81
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $766 · 2022: $443 · 2023: $558 · 2024: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $512.62 | 2021-2024 | Yukon Oct Spinal System, Prolift, N/A |
| Teva Pharmaceuticals USA, INC. | $348.41 | 2021-2024 | Austedo Xr, Austedo |
| Abbvie INC. | $108.87 | 2022-2023 | |
| Argenx US, INC. | $103.21 | 2022-2024 | Vyvgart Hytrulo |
| Ucb, INC. | $102.17 | 2021-2023 | Briviact |
| Octapharma USA, INC. | $94.16 | 2022-2023 | Panzyga |
| Biohaven Pharmaceuticals, INC. | $80.19 | 2021 | |
| Sk Life Science, INC. | $71.11 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $55.23 | 2023 | Ultomiris |
| Lilly USA, LLC | $53.10 | 2023 | Amyvid, Emgality |
| Takeda Pharmaceuticals U.S.A., INC. | $42.53 | 2021-2022 | |
| Lundbeck LLC | $41.70 | 2021 | |
| Jazz Pharmaceuticals INC. | $41.38 | 2022 | |
| Acorda Therapeutics, INC | $38.96 | 2021 | |
| Merz Pharmaceuticals, LLC | $38.33 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $34.31 | 2021 | |
| Banner Life Sciences, LLC | $33.79 | 2021 | |
| Neurocrine Biosciences, INC. | $31.20 | 2023 | Ingrezza, Ongentys |
| Biogen, INC. | $25.75 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.11 | 2024 | Lifevest |
| Neurelis, INC. | $20.25 | 2023 | Valtoco |
| Avion Pharmaceuticals | $18.93 | 2022 | |
| Aquestive Therapeutics, INC. | $16.51 | 2021 | |
| Aprecia Pharmaceuticals, LLC | $16.26 | 2022 | |
| Amgen INC. | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Kindelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.